ISTA Pharmaceuticals Announces Preliminary Results of T-Pred Studies Sep 9, 2009
Sept. 8 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ), today announced preliminary results from two recently completed studies on its investigational ophthalmic product, T-Pred(TM) (prednisolone acetate 1 ... About ISTA Pharmaceuticals ... ISTA Pharmaceuticals is the fourth largest branded ophthalmic pharmaceutical business in the U.S. ISTA's three marketed products plus its product candidates include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. (PR Newswire)
ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies Sep 9, 2009
Sept. 8 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ) today announced the U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ophthalmic solution) 1 ... Full prescribing information is available on ISTA Pharmaceuticals' website at ... About ISTA Pharmaceuticals. (PR Newswire)
ISTA says daily Xibrom eye drops met goal in study Aug 27, 2009
ISTA Pharmaceuticals Inc. on Wednesday reported successful late-stage clinical trial results for Xibrom QD, a new once-per-day eye drug ... ISTA Pharmaceuticals Inc. (Yahoo News -- Pharmaceutical Industry News)
FDA panel backs Ista drug for eye allergies Jun 27, 2009
WASHINGTON A panel of federal experts said Friday an anti-itching drug from eye care company Ista Pharmaceuticals is safe and effective, according to a government spokeswoman ... -based Ista Pharmaceuticals rose 21 cents, or 4 ... Ista Pharmaceuticals. (Yahoo News -- Pharmaceutical Industry News)
FDA says Ista eye drug has no serious side effects Jun 26, 2009
WASHINGTON Federal health scientists said Wednesday an anti-itching drug from eye care company Ista Pharmaceuticals did not show any serious side effects in testing on patients ... -based Ista Pharmaceuticals rose 26 cents, or 6 ... Ista Pharmaceuticals. (Yahoo News -- Pharmaceutical Industry News)
ISTA Pharmaceuticals Announces Conference Call and Webcast of First Quarter 2009 Financial Results Apr 18, 2009
April 17 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ), today announced it will release first quarter 2009 financial results on May 7, 2009, and will host a conference call to discuss these results and provide a pipeline update at 5:00 p.m. Eastern Time ... ISTA Pharmaceuticals is an ophthalmic pharmaceutical company ... The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share, thereby continuing its growth... (PR Newswire)
